@anjuzhang.bsky.social
Emergence of acquired HIV drug resistance among individuals receiving dolutegravir-based antiretroviral therapy in Uganda: A national laboratory-based survey 2023
✅ Just Accepted
🔗 https://bit.ly/482RwkM
✅ Just Accepted
🔗 https://bit.ly/482RwkM
November 11, 2025 at 4:04 PM
Let's Get It Started: Early ART after HIV Acquisition Reduces Non-AIDS-Defining Malignancies
✅ Just Accepted
🔗 https://bit.ly/47zpRbh
✅ Just Accepted
🔗 https://bit.ly/47zpRbh
November 11, 2025 at 4:03 PM
National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47Mx2wE
October 31, 2025 at 2:24 PM
Risk factors for Lyme disease in the general population - a survey of adults and caregivers in 28 states
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hCops2
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hCops2
October 31, 2025 at 2:24 PM
Serum IgG1 and IgG3 antibodies to Chlamydia trachomatis Pgp3 and Hsp60 in men of subfertile couples
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47AZIsi
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47AZIsi
October 23, 2025 at 11:32 PM
CMV is a very tough target. Disappointing to see that the mRNA vaccine candidate from moderna showed little protective effect against congenital CMV infecton. Ongoing phase 2 trials of the vaccine in transplant population is continuing.
www.fiercebiotech.com/biotech/mode...
www.fiercebiotech.com/biotech/mode...
Moderna scraps congenital virus program after vaccine shows little protective effect in phase 3
Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women from the virus in a large phase 3 trial, the biotech announced in a post | ...
www.fiercebiotech.com
October 23, 2025 at 11:32 PM
Changes in body mass index in children and adolescents living with HIV in Europe and Thailand starting dolutegravir
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48zBrUJ
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48zBrUJ
October 23, 2025 at 11:31 PM
Trends in Persons Prescribed HIV Postexposure Prophylaxis in the United States, 2015?2023
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48IyEIL
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48IyEIL
October 23, 2025 at 11:31 PM
Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
#IDSky
#IDSky
Validate UserNoninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
A next-generation, serum-free, highly purified Vero cell rabies vaccine, PVRV-NG2, is in development.
bit.ly
October 13, 2025 at 11:42 PM
Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
#IDSky
#IDSky
Validate UserNoninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
A next-generation, serum-free, highly purified Vero cell rabies vaccine, PVRV-NG2, is in development.
bit.ly
October 13, 2025 at 11:41 PM
Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product Recommendations
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4h5Pi7d
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4h5Pi7d
October 11, 2025 at 1:56 PM
Restoring TB-specific immunity in early HIV infection ? the dual promise of early antiretroviral and TB preventive treatment
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42rFNcE
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42rFNcE
October 11, 2025 at 1:55 PM
Safety of Bacillus Calmette-Guérin vaccination and impact on HIV-1 latent reservoir size in people with treated HIV-1 Infection
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4o3I5a5
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4o3I5a5
October 11, 2025 at 1:55 PM
Role of local and population-based data in Advanced HIV Disease in the ICU
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KJ3GWW
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KJ3GWW
October 11, 2025 at 1:55 PM
The burden of Surgical Site infections with pathogens presumably resistant to perioperative prophylaxis in orthopaedic tumour surgery: Secondary analysis of the PARITY trial
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Kzg3oF
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Kzg3oF
October 11, 2025 at 1:55 PM
Features of carbapenem-resistant Gram-negative bacterial infections in Japan based on the setting of onset
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Features of carbapenem-resistant Gram-negative bacterial infections in Japan based on the setting of onset
Carbapenem-resistant Gram-negative bacilli (CR-GNB) are a major public health threat, traditionally linked to hospital settings. Howeve
bit.ly
October 11, 2025 at 1:55 PM
Infectious disease expert calls for national sepsis standard in Canada https://www.ctvnews.ca/video/2025/09/13/infectious-disease-expert-calls-for-national-sepsis-standard-in-canada/
𝗚𝗲𝘁 𝘄𝗲𝗲𝗸𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 ⇢ CanadaHealthwatch.ca/newsletter
𝗚𝗲𝘁 𝘄𝗲𝗲𝗸𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 ⇢ CanadaHealthwatch.ca/newsletter
September 15, 2025 at 1:00 PM
Vaccination of frontline health workers and contacts of people infected with #Ebola has begun in the #DRC’s Kasai Province where an outbreak of the disease has been declared: www.afro.who.int/countries/de...
September 15, 2025 at 1:00 PM
🚨 Ebola Outbreak – Kasai, DRC 🇨🇩
📢 1st SitRep from WHO Country Office
👩🍼 Index case: pregnant woman admitted Aug 20, died Aug 25
📊 28 suspect cases | 15 deaths (54% CFR) | 4 HCWs 🧑
🛡️ Response: surveillance, contact tracing, isolation + 2,000 Ervebo doses 💉
🧬Sequencing: confirms new spillover event
📢 1st SitRep from WHO Country Office
👩🍼 Index case: pregnant woman admitted Aug 20, died Aug 25
📊 28 suspect cases | 15 deaths (54% CFR) | 4 HCWs 🧑
🛡️ Response: surveillance, contact tracing, isolation + 2,000 Ervebo doses 💉
🧬Sequencing: confirms new spillover event
September 8, 2025 at 7:18 PM
Ethnic disparities in extrahepatic manifestations among people with HCV infection: a population-based study in British Columbia
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Ethnic disparities in extrahepatic manifestations among people with HCV infection: a population-based study in British Columbia
Ethnic disparities in extrahepatic manifestations (EHMs) among individuals with chronic hepatitis C virus (HCV) infection are poorly understood, especially in diverse populations.
bit.ly
September 8, 2025 at 7:17 PM
On Science Speaks blog: Several authors of IDSA’s new guidelines on the management and treatment of complicated urinary tract infections answer questions about new recommendations and updates. www.idsociety.org/science-spea...
Complicated urinary tract infections: New guidelines Q&A
Several authors of IDSA’s new guidelines for treating and managing complicated urinary tract infections answer questions about the recommendations and highlight key updates.
www.idsociety.org
September 3, 2025 at 10:50 PM
Single-cell and plasma proteomics do not differentiate patients with and without SARS-CoV-2 antigenemia in convalescence in a cohort of 100 patients
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Single-cell and plasma proteomics do not differentiate patients with and without SARS-CoV-2 antigenemia in convalescence in a cohort of 100 patients
Plasma samples obtained approximately three (n=100) and 12 months (n=78) after acute SARS-CoV-2 infection were tested for S1, spike, and...
doi.org
September 3, 2025 at 10:50 PM
Proportions of U.S. Blood Donors with Serological Evidence of SARS-CoV-2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Proportions of U.S. Blood Donors with Serological Evidence of SARS-CoV-2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022
The proportion of SARS-CoV-2 infections diagnosed by COVID-19 tests, including home antigen tests, is unknown. We detected infections among U.S. blood donors by testing for nucleocapsid antibody (anti-N) seroconversion and administered a questionnaire to determine the proportion of those infections that were associated with a self-reported positive COVID-19 test.
doi.org
April 21, 2025 at 6:58 PM
Subgroup analyses in randomized trials of Clostridioides difficile associated disease: Recurring Challenges with Analyzing Recurrence
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Subgroup analyses in randomized trials of Clostridioides difficile associated disease: Recurring Challenges with Analyzing Recurrence
doi.org
April 21, 2025 at 6:58 PM
Serological Responses and Pregnancy Outcomes in Women with Serofast Syphilis: Efficacy of Re-treatment in a Prospective Nested Case-Control Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Serological Responses and Pregnancy Outcomes in Women with Serofast Syphilis: Efficacy of Re-treatment in a Prospective Nested Case-Control Study
There are inconsistencies in guidelines concerning the necessity for anti-syphilis re-treatment during pregnancy for women who tested seropositive despite having received treatment before pregnancy.
doi.org
April 19, 2025 at 12:48 PM